Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin and Metronidazole for Peri-implantitis
NCT04149327Phase 4Completed
- Sponsor
- University Medical Center Groningen
- Start
- Aug 2012
- Primary completion
- Dec 2019
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, single-blind trial of amoxicillin and metronidazole in peri-implantitis, sponsored by University Medical Center Groningen. Primary endpoint: Change from baseline mean peri-implant bleeding score at 3 months. Started Aug 2012; status: completed.
02
Drugs
amoxicillinmetronidazole
03
Conditions
peri-implantitis
Beyond the preview
Go deeper on NCT04149327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04149327.